RUNX1 and leukemia: Using a lineage-specific oncogenic activation approach, Vicente-Duenas and colleagues demonstrated that ETV6-RUNX1 can give rise to both B-ALL and T-ALL and that leukemia transformation is dependent from the nature of the acquired secondary mutations [143].